Scientists find a new layer of Alzheimer’s hidden in the genome

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-13T14:21:59.757Z • Permanent link

Scientists at the University of California, San Francisco, led by Dr. Rebecca Dutton, a renowned neuroscientist, have made a groundbreaking discovery about Alzheimer's disease. The research team, which includes experts from the University of California, San Diego, and the University of Oxford, has found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer's. This disruption, known as epigenetic changes, alters how important genes are switched on and off, leading to the disease's progression. The study, published in the journal Nature, provides a significant breakthrough in understanding the underlying mechanisms of Alzheimer's, which has long been a mystery to researchers.

The discovery was made using advanced imaging techniques, including single-molecule localization microscopy (SMLM) and cryo-electron microscopy (cryo-EM), which allowed the researchers to visualize the 3D structure of DNA in the brain cells. The team analyzed the DNA of brain cells from patients with Alzheimer's disease and compared it to healthy brain cells. They found that the 3D organization of DNA was disrupted in several types of brain cells, including neurons, astrocytes, and microglia. These disruptions were associated with changes in gene expression, which is the process by which genes are turned on or off.

The research was funded by the National Institutes of Health (NIH) and the Alzheimer's Association, and was conducted at the University of California, San Francisco. The study's findings have significant implications for the development of new treatments for Alzheimer's disease. By understanding the underlying mechanisms of the disease, researchers may be able to develop new therapies that target the disrupted DNA organization. The study's authors are optimistic about the potential of their findings to lead to new treatments for Alzheimer's.

The discovery of disrupted DNA organization in Alzheimer's disease has significant implications for the Data Sources domain. Companies such as Illumina and BGI, which specialize in genetic sequencing and analysis, may see an increase in demand for their services as researchers seek to understand the genetic basis of the disease. The study's findings also highlight the importance of epigenetic changes in the development of Alzheimer's disease, which may lead to new approaches to understanding the disease's progression. Research communities, including those focused on neurology and genetics, will be closely watching the development of new treatments based on this research.

The study's findings also have significant implications for the market for Alzheimer's disease therapies. Companies such as Pfizer and AstraZeneca, which have developed drugs to treat Alzheimer's disease, may need to revisit their approaches based on this research. The study's authors suggest that their findings could lead to the development of new treatments that target the disrupted DNA organization in brain cells. This could lead to more effective treatments for Alzheimer's disease, which is a major public health concern worldwide. The study's findings also highlight the importance of investing in basic research, which can lead to significant breakthroughs in our understanding of complex diseases.

The discovery of disrupted DNA organization in Alzheimer's disease is part of a larger pattern of research that seeks to understand the underlying mechanisms of complex diseases. In recent years, there has been a growing recognition of the importance of epigenetic changes in the development of diseases such as cancer and cardiovascular disease. Researchers have also been exploring the use of advanced imaging techniques to visualize the 3D structure of DNA and other biomolecules.